Diabetes News and Innovations

Orange Biomed successfully concludes Series A1 investment

Orange Biomed Successfully Raises 3 Billion KRW in Series A1 Funding Round

Recognition of clinical research results for innovative microfluidic technology-based portable glycated hemoglobin meter, participation in CES Eureka Park in 2025 to fully advance into the US market.
The Good Men Project

The Good Men Project Featured Content / Yeaseul Park: Orange Biomed’s New Diabetes Device

Yeaseul Park, CEO of Orange Biomed, is a Forbes 30 Under 30 honoree. What is the efficacy of this new device? Interview by Scott Douglas Jacobsen. Park discusses the development of their innovative A1C diabetes management device…
Orange Biomed Contribute to BIOSPECTRUM Asia edition, volume 19

Digital Innovations in Diabetes Care (BioSpectrum Asia Edition, Volume 19 | Issue 11 | November 2024)

“Ultimately, this leads to better health outcomes by making diabetes management more accessible and proactive,” said Yeaseul Park, Co-Founder and Co-President  Orange Biomed, USA. 
'ORANGE BIOMED TO SHOWCASE FIRST-EVER MICROFLUIDIC-BASED A1C TEST AT MEDICA 2024 DURING DIABETES AWARENESS MONTH' - a news covered by smb world report

Orange Biomed to Showcase First-Ever Microfluidic-Based A1C Test at MEDICA 2024 During Diabetes Awareness Month

Award-Winning, Novel Single-Cell Analysis Technology in a Device Designed to Accurately Measure A1C from One…
'ORANGE BIOMED RECOGNIZED GLOBALLY WITH KHF INNOVATION AWARD FOR PIONEERING MICROFLUIDIC TECHNOLOGY APPLICATION' - a news covered by new product watchh

Orange Biomed Recognized Globally with KHF Innovation Award for Pioneering Microfluidic Technology Application

OBM rapid A1c is a Breakthrough Microfluidic-Based Testing Device to Redefine Diabetes Management Worldwide…
'Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology Meeting.' News Covered By drug delivery business

Orange Biomed to showcase microfluidic-based A1C test

Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology Meeting…

Press Release: Orange Biomed Unveils World’s First Microfluidic-Based A1C Test at the Diabetes Technology Meeting’s Startup Showcase

Attendees get an early preview of Orange Biomed’s revolutionary A1C testing method, recognized as a groundbreaking solution with anticipated release in 2025…

Download Our Media Kit

For patients with diabetes and healthcare professionals that want an easy-to-use portable A1c testing device, Orange Biomed…
Orange Biomed revealed its latest technology at the 83rd Scientific Sessions of the American Diabetes Association (ADA)

A New HbA1c Test Based on a Cellular Stiffness Measurement of Red Blood Cells

In the United States, more than 1 in 5 people with diabetes do not know they have diabetes, and they are at higher risk…
The Role of Corporate Social Responsibility for U.S. Market Entry and Expansion – Expediting Value Across Industries Through Community Efforts

The Role of Corporate Social Responsibility for U.S. Market Entry and Expansion – Expediting Value Across Industries Through Community Efforts

When S. Korean companies attempt to enter or expand within the U.S. market, they often confront obstacles due to their…
Orange Biomed news covered By MTO

Orange Biomed acquires ISO 9001 certification for quality management system

Glycated hemoglobin, a glycated protein in which sugar is bound to hemoglobin in red blood cells, is the most important…
Biotimes took an interview of Orange Biomed's CEO.

CEO Interview: Orange BioMed Revolutionizes Diabetes Management: HbA1c Measurement with a Drop of Blood

Glycated hemoglobin, a glycated protein in which sugar is bound to hemoglobin in red blood cells, is the most important…
'Orange Biomed selected as 2023 “First Penguin ” by Korea Credit Guarantee Fund', News Covered By Asia Economy

Orange Biomed selected as 2023 “First Penguin ” by Korea Credit Guarantee Fund

Orange Biomed, a venture company developing a microfluidic-based glycated hemoglobin measurement medical device…
Orange Biomed Featured On diabetes journals

A New Portable HbA1c Meter—Red Blood Cell Deformability–Based HbA1c Test

In the United States, more than 1 in 5 people with diabetes do not know they have diabetes, and they are at higher risk…
Orange Biomed News covered by MPO-MAG

Orange Biomed Reveals Home A1c Test in U.S.

Orange Biomed, a diabetes management tech startup, has launched its OBM rapid A1c test in the U.S. OBM rapid A1c…
Orange Biomed Featured on hospimedica

Portable, Pocket-Sized A1c Testing Device Delivers Results in 5 Minutes From Single Blood Drop

Diabetes stands as a primary contributor to mortality rates and accounts for a significant portion of healthcare expenses…
Orange Biomed News Covered By medical device Network

Orange Biomed launches OBM rapid A1c test in the US

Healthcare start-up Orange Biomed has launched its pocket-sized, reusable OBM rapid A1c test in the US to fill the testing…
Orange Biomed Featured On 360dx

Diabetes Startup Firm Orange Biomed Launches in U.S.

South Korean startup Orange Biomed announced Wednesday its US launch with…
Orange Biomed News covered by Sandiegometro

Orange Biomed to unveil latest technology in San Diego

Orange Biomed, a North Carolina health care startup with cutting-edge diabetes management technology…
Orange Biomed News is covered By Mass Device

Orange Biomed unveils at-home A1c test in the U.S.

Orange Biomed announced today that it commenced a U.S. launch as it looks to fill testing gaps for pre-diabetes and diabetes…
Orange Biomed Featured On Medical device news magazine

Orange Biomed Launches in U.S. Market to Reduce Inaccuracies in Diabetes Diagnosis for Minorities and Help Manage Diabetes at Home with a Revolutionary POC A1c Test

Orange Biomed, a North Carolina health care startup with cutting-edge diabetes management technology…
Orange Biomed is featured in the article '11 diabetes tech startups you need to know', by medical design and Outsourcing

11 diabetes tech startups you need to know

The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps…
OBM Rapid A1c is featured in the article '11 Diabetes Tech Startups You Need to Know,' by Drug Delivery Business.

OBM rapid A1c featured listed in “11 diabetes tech startups you need to know”

The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps and…
'Orange Biomed Highlighted as Top Technology Presented in Pitchfest Sponsored by Mayo Clinic Collaborative Services', the news Covered by pharm news

Founder Interview: Catch Diabetes ‘Unmet Need’ with Quick, Accurate and Simple Glycated Hemoglobin Management

The number of patients with diabetes and pre-diabetes is rapidly increasing not only in Korea but also around the world…
Orange Biomed Highlighted as Top Technology Presented in Pitchfest Sponsored by Mayo Clinic Collaborative Services

Orange Biomed Highlighted as Top Technology Presented in Pitchfest Sponsored by Mayo Clinic Collaborative Services

Last February, BDMT Global, an American global business development company, successfully completed the ‘DAC…
Orange Biomed Co-Founder, Yeaseul Park, Featured in Forbes Korea’s 30 Under 30 List

Orange Biomed Co-Founder, Yeaseul Park, Featured in Forbes Korea’s 30 Under 30 List

Orange Biomed, established in 2021, succeeded in developing the world’s first glycated hemoglobin measuring…
Orange Biomed Interview By MIT Technology

MIT Technology Interview: Glycated Hemoglobin Biomarker Prevents Diabetic Complications

Orange Biomed developed a glycated hemoglobin analyzer using microfluidic technology the size of red blood cells…
Orange Biomed Highlighted in Fortune Korea Expert Opinion Report

Orange Biomed Highlighted in Fortune Korea Expert Opinion Report

In 2021, CEOWorld Magazine ranked S. Korea to be #1 among global healthcare systems, hardly its first Health Care Index…
Orange Biomed Featured In CB Insights

Unbundling Diabetes: How tech is transforming the care and management of this disease

For over 100 years, insulin has revolutionized diabetes care by providing patients with a treatment to help manage the disease…
Orange Biomed News is covered by etnews

Orange Biomed Develops a Portable HbA1c Analyzer

A technology that can check glycated hemoglobin, which previously had to be measured using expensive…
Medical Device Startup 'Orange Biomed' Attracts 1.6 Billion Won in Pre-A Investment| Orange Biomed Featured On platum

Orange Biomed Attracts $1.6B Won in Pre-Series A Investment Round from Seoul New Technology Investment Company and Digital Healthcare Partners

‘Orange Biomed’, a diabetes in vitro diagnostic medical device startup, attracted 1.6 billion won in pre-Series A round investment…
Microengineered Materials with Self-Healing Features for Soft Robotics” Article Recognized as Top Downloaded Article by Wiley

“Microengineered Materials with Self-Healing Features for Soft Robotics” Article Recognized as Top Downloaded Article by Wiley

Soft bodied invertebrates and vertebrates have been an inspiration for the development of soft robots.[1, 2] Compared to robots…